PDMR Notification & Director Shareholding (1764141)
02 Noviembre 2023 - 12:20PM
UK Regulatory
Arix Bioscience PLC (ARIX)
PDMR Notification & Director Shareholding
02-Nov-2023 / 18:20 GMT/BST
=----------------------------------------------------------------------------------------------------------------------
Arix Bioscience plc
("Company")
PDMR Notification & Director Shareholding
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons
closely associated with them
The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 60,000 Ordinary
shares of 0.001 pence each in the Company ("Shares") on 2nd November 2023 at a price of GBP1.1469 per share.
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name
Peregrine Moncreiffe
2 Reason for the notification
a) Position/status Non-Executive Director and Chair of the
Board
b) Initial notification /Amendment
Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction
monitor
a) Name
Arix Bioscience plc
b) LEI 213800OVT3AHQCXNIX43
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Arix Bioscience plc Ordinary shares of 0.001
pence each
Identification code GB00BD045071
b) Nature of the transaction
Share purchase
Price(s) and volume(s) Price(s)GBP Volume(s)
c) 60,000
1.1469
Aggregated information
d)
- Aggregated volume 60,000
- Price GBP68,815.20
e) Date of the transaction
2 November 2023
f) Place of the transaction
Outside a trading venue
For further information please contact: Kin Company Secretarial
Limited, Company Secretary +44 20 8819 6486
-----------------------------------------------------------------------------------------------------------------------
Dissemination of a Regulatory Announcement, transmitted by EQS
Group. The issuer is solely responsible for the content of this
announcement.
-----------------------------------------------------------------------------------------------------------------------
ISIN: GB00BD045071
Category Code: DSH
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.: 282417
EQS News ID: 1764141
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1764141&application_name=news
(END) Dow Jones Newswires
November 02, 2023 14:20 ET (18:20 GMT)
Arix Bioscience (LSE:ARIX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Arix Bioscience (LSE:ARIX)
Gráfica de Acción Histórica
De May 2023 a May 2024